This content is machine translated ICML 2017 in Lugano Long-term data are positive At the ICML Congress, the audience gained insight into long-term data from two phase III trials in mantle cell lymphoma and chronic lymphocytic leukemia. The new results confirm the statements…
View Post 7 min This content is machine translated Surgical therapy Surgical aspects in breast carcinoma Breast-conserving therapy is the standard of surgical treatment for breast carcinoma and should be offered to all age groups. Mastery of oncoplasty is an important foundation for meeting both oncologic…
View Post 10 min This content is machine translated Breast Cancer Complementary medicine for side effects of antihormonal treatment Numerous studies have been published regarding new options for complementary medicine treatment for side effects of antihormonal therapies. Some of the affected patients may benefit from complementary medicine treatment options.…
View Post 8 min This content is machine translated Cancer screening programs Mammography screening in Switzerland About half of the Swiss cantons now offer a breast screening program. The goal of systematic breast screening is to reduce mortality. Discussions about the benefits of breast screening are…
View Post 8 min This content is machine translated ASCO 2017 in Chicago Groundbreaking on tumors of the prostate and gallbladder There was big news at the 2017 ASCO Congress. First, abiraterone is pushing into the first-line setting in metastatic prostate cancer. On the other hand, there is a new standard…
View Post 7 min This content is machine translated Complementary medicine in breast carcinoma Opportunity for improved oncology therapy and compliance Complementary medicine is desired and used by very many breast cancer patients. For the treating physician, competent handling is an opportunity to improve oncological therapy and increase compliance.
View Post 9 min This content is machine translated Adjuvant system therapy of breast carcinoma Current standards of adjuvant therapy according to tumor subtype Adjuvant systemic treatment improves survival and freedom from recurrence in early breast cancer. Genetic testing of the tumor can help in the choice of therapy. Supportive monitoring is useful even…
View Post 11 min This content is machine translated Curatively treated NSCLC Update on aftercare Approximately half of patients with newly diagnosed NSCLC can be treated with curative therapy. In the first three years thereafter, the likelihood of relapse is greatest. There is no good…
View Post 6 min This content is machine translated Zurich Dermatology Training Days Current research in a nutshell There were numerous interesting developments from research in 2017. Including comparative studies on bullous pemphigoid and new guidelines on cosmetic treatments under isotretinoin. There’s also news on melanoma.
View Post 4 min This content is machine translated PD1/PD-L1 in second-line therapy for metastatic NSCLC. The agony of choice The treatment of bronchial carcinoma is greatly changed by immunotherapy. Current developments will lead to an adjustment of our therapy algorithms in the coming months.
View Post 6 min This content is machine translated Oncological prevention To what extent is nutrition crucial? Approximately one-fifth of all cancers are caused by diet, overweight and obesity. Crucial in terms of cancer development are mainly too much red and processed meat, alcohol and salt; little…